Getwell Pharma India Private Limited, a active private limited company, was established on 19 January 2017 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24290DL2017PTC310791. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹34.75 Cr and a paid-up capital of ₹32.75 Cr.
Formerly known as Getwell Pharma Innovations Private Limited, Getwell Pharma India Private Limited. It upholds a compliant status. Employing 111 professional, Its leadership includes Manas Tandon (Director), Mini Tandon (Director), Rakesh Dwivedi (Director). Past directors included Ashok Kumar Vaid, Rajiv Tandon, Rakesh Dwivedi. It holds ₹42.19 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No 721, Sector 19 Pocket 3, Delhi, Delhi, 110075.
U24290DL2017PTC310791
310791
19 January 2017
₹34.75 Cr
₹32.75 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Getwell Pharma India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manas Tandon | Director | 19 Jan 2017 | Current |
| Mini Tandon | Director | 19 Jan 2017 | Current |
| Rakesh Dwivedi | Director | 16 Oct 2023 | Current |
| Prerna Tandon | Director | 15 Apr 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 Dec 2020 | Past |
| Pramod Abcsdd | Director | 25 Jan 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Getwell Pharma India Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 59.9% decrease. The company also saw a substantial improvement in profitability, with a 1543.08% increase in profit. The company's net worth Soared by an impressive increase of 20.18%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Getwell Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹421,920,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Nov 2024 | State Bank Of India | ₹9.00 M | Open |
| 23 Feb 2024 | State Bank Of India | ₹0.58 M | Open |
| 03 Aug 2023 | Hdfc Bank Limited | ₹1.44 M | Open |
| 31 May 2022 | State Bank Of India | ₹3.50 Cr | Open |
| 22 Jul 2020 | State Bank Of India | ₹1.40 Cr | Open |
Explore comprehensive loan charge details -
Getwell Pharma India has a workforce of 111 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Getwell Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Getwell Pharma India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with State Bank Of India amounted to Rs. 0.90 Cr with Charge ID 101010153 was registered on 13 Nov 2024. was completed.
The activity A charge with State Bank Of India of Rs. 36.19 Cr registered on 18 Jun 2018 with Charge ID 100228775 was modified on 22 Oct 2024. was completed.
The activity Getwell Pharma India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Getwell Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
A charge with State Bank Of India amounted to Rs. 0.06 Cr with Charge ID 100884408 was registered on 23 Feb 2024. was recorded as a recent event.
Progress on Rakesh Dwivedi was appointed as a Director was appointed as a Director on 16 Oct 2023 & has been associated with this company since 2 years 1 month . was documented.
The CIN of Getwell Pharma India Private Limited is U24290DL2017PTC310791.
Getwell Pharma India Private Limited is headquartered at Flat No 721, Sector 19 Pocket 3, Delhi, Delhi, 110075.
Getwell Pharma India Private Limited was incorporated on 19 January 2017.
The current directors of Getwell Pharma India Private Limited are
The primary industry of Getwell Pharma India Private Limited is Manufacturing.
Getwell Pharma India Private Limited is unlisted.
The authorized capital of Getwell Pharma India Private Limited is ₹34.75 Cr, and the paid-up capital is ₹32.75 Cr.
The compliance status of Getwell Pharma India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX